A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment

Doxorubicin-induced cardiomyopathy (DOX-CM) is a severe complication of doxorubicin (DOX) chemotherapy. Characterized by cumulative and irreversible myocardial damage, its pathogenesis has not been fully elucidated. Shengmai Injection (SMI), a Traditional Chinese Medicine, may alleviate myocardial i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu, Tang, Yong, Zhang, Ya-Chen, Huang, Xiao-Hong, Xie, Yu-Quan, Xiang, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418690/
https://www.ncbi.nlm.nih.gov/pubmed/25938766
http://dx.doi.org/10.1371/journal.pone.0125209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418690/
https://www.ncbi.nlm.nih.gov/pubmed/25938766
http://dx.doi.org/10.1371/journal.pone.0125209

Ejemplares similares